No Data
No Data
No Data
No Data
No Data
Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
HAYWARD, Calif.--(BUSINESS WIRE)--Apr. 24, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, tod
Pulse BiosciencesApr 24 00:00 ET
After the Recent Decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's Holdings Have Lost 13% of Their Value
Key Insights Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable ownership 68% of the company is held by a single shareholder (Robert Duggan) Using da
Simply Wall StApr 5 07:19 ET
Pulse Biosciences to Sell Subscription Rights to Purchase up to 6M Units
Seeking AlphaApr 4 10:00 ET
Express News | Pulse Biosciences Shares Are Trading Lower After the Company Last Week Reported Q4 Financial Results. Also, the Company Announced Plans to Initiate a Rights Offering of up to $60 Million Worth of Units
Moomoo 24/7Apr 1 13:24 ET
Precision Biosciences, Mesoblast, Pulse Biosciences Among Healthcare Movers
Seeking AlphaApr 1 10:00 ET
Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects PVH Corp. (NYSE:PVH) to report quarterly earn
BenzingaApr 1 03:33 ET
No Data
No Data